US EditionA Mother’s Day visit to my daughter ended up a health boost
Summary by Hypoparathyroidism News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
A Mother’s Day visit to my daughter ended up a health boost
“You’re never too old to need your mom.” — Drew Vapnek Life with hypoparathyroidism, more simply nicknamed hypopara, is so unpredictable. I never know if I’ll have a good or bad day. The past few months have been a roller coaster as I wean down from my 60 mcg dose of Yorvipath (palopegteriparatide), which I’m taking as part of a Phase 2 clinical trial, to 30 mcg, a dose approved by the U.S. Food and Drug Administration. Since then, I’ve experien…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
